Mammoth Biosciences to Develop CRISPR-based Diagnostics, Biosurveillance Platforms
Under the program, Mammoth will leverage its robust DETECTR platform for CRISPR-based diagnostics to detect emerging biological threats.
Category: Company News
Company News
Latest
Company News
Latest
Sema4 Opens Second Clinical Lab in Connecticut
The new 70,000-square-foot clinical laboratory in Stamford will have more than 300 employees.
Company News
Popular
Philips, Singapore General Hospital to Establish Digital and Computational Pathology Center of Excellence
The SGH Center of Excellence aims to advance pathology practice by implementing a fully digital histopathology workflow and deploying AI to increase productivity.
HHS Launches Pilot Program of Fast Molecular POC Test for Covid-19
Alaska, Florida, Louisiana, New Jersey, and Texas will receive the first shipments of the test used in the NBA bubble.
Read More
APC Health Authorized for SalivaDirect Noninvasive Covid-19 Test
The SalivaDirect covid-19 test provides analytical sensitivity of 99% and is accurate 94% of the time.
Read More
Profiles in Leadership
From CEOs to Nobel laureates, women are making their mark in the clinical sciences.
Read More
Proscia’s Concentriq Selected for Joint Pathology Center
End-to-end transformation will enable groundbreaking biomedical research, advance precision medicine initiatives, and improve routine diagnosis.
Read More
CompuGroup Medical Hosts its First Virtual User Conference
The virtual conference will help laboratory technicians, lab managers, and other specialists better use CGM LabDAQ to create a laboratory that runs as effectively and efficiently as possible.
Read More
Abbott Gains Access to Quanterix Bead-Based Technology Patents for IVD
The nonexclusive license grants Abbott access to Quanterix’ portfolio of bead-based technology patents for use in in vitro diagnostic applications.
Read More
19 Organizations Unite to Form Covid-19 Testing Consortium
The goal of the Covid-19 Testing Industry Consortium is to inform, improve, innovate, and accelerate various aspects of testing, ranging from research to clinical diagnostic applications.
Read More
NIH RADx Initiative Advances Six New Covid-19 Testing Technologies
The addition of new, rapid point-of-care platforms will expand national testing options.
Read More
Labs Struggled With Surge in Covid-Testing Demand; How One Made It Through
BioReference Labs shut down temporarily in July in a controversial move that helped it win new business and prepare for the coming flu season.
Read More
Quest Launches Three Combined Covid-19 and Respiratory Virus Tests
Nearly 20 viral and bacterial infections can be identified from a single swab, reducing time to diagnose and treatment.
Read More
Illumina to Acquire Grail to Enhance Cancer Detection
Grail will operate as a standalone division within Illumina, currently working on readying the Galleri multi-cancer screening test for launch.
Read More
Ceres Awarded $243,000 to Develop Viral Pathogen Surveillance Tools
Ceres will use this CDC award to adapt its Nanotrap Virus Particles to enable a workflow that is inexpensive, easy to use, and rapid enough to integrate with new portable RNA and DNA viral sequencing tools.
Read More
Global Partnership to Offer 120 Million Covid-19 Rapid Tests for Low- and Middle-Income Countries
The rapid diagnostics from Abbott and SD Biosensor will enable expanded testing in countries that do not have extensive laboratory facilities.
Read More
Qiagen Fully Acquires NeuMoDx Molecular
The acquisition rounds out Qiagen’s portfolio of automated molecular testing solutions based on the proven PCR technology.
Read More
Siemens, CDC Collaborating to Define Threshold for Covid-19 Immunity
The thresholds displayed in the standardized unit of measure for IgG may lead to a standardized interpretation of covid-19 immunity through test results.
Read More